Literature DB >> 8997174

Analytical methods for the characterization and quality control of pharmaceutical peptides and proteins, using erythropoietin as an example.

D Gilg1, B Riedl, A Zier, M F Zimmermann.   

Abstract

In the last twenty years many peptides and proteins were introduced to the market for pharmaceutical use. The high complexity of the biomacromolecules requires the use not only of physicochemical methodologies but also of immunochemical and biological techniques for the characterization and quality control of these substances. Characterization of the active conformation and post-translational modifications is important for the understanding of the in vivo activity of peptides and proteins. Among other spectroscopic techniques circular dichroism has become a helpful tool for evaluating the secondary and tertiary structure of proteins and peptides. A combination of several analytical methods is necessary for a comprehensive characterization of the substance under investigation and for an appropriate quality control of the product concerning identity, purity and potency. Suitable analytical methodologies are discussed using erythropoietin as an example.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997174     DOI: 10.1016/s0031-6865(96)00048-9

Source DB:  PubMed          Journal:  Pharm Acta Helv        ISSN: 0031-6865


  4 in total

Review 1.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

2.  Future of sustained protein delivery.

Authors:  Ravi Vaishya; Ashim K Mitra
Journal:  Ther Deliv       Date:  2014-11

3.  Development and validation of RP-HPLC and RP-UPLC methods for quantification of erythropoietin formulated with human serum albumin.

Authors:  Shaligram S Rane; Alkesh Ajameri; Rustom Mody; P Padmaja
Journal:  J Pharm Anal       Date:  2011-11-29

4.  A Reference Standard for Analytical Testing of Erythropoietin.

Authors:  Huiping Tu; Kevin Carrick; Rebecca Potts; Mark Hasselberg; Mark Verdecia; Chris Burns; Ben Cowper; Fouad Atouf
Journal:  Pharm Res       Date:  2022-03-15       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.